Filing Details

Accession Number:
0001437749-22-016306
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-30 17:52:37
Reporting Period:
2022-06-30
Accepted Time:
2022-06-30 17:52:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1742927 Reviva Pharmaceuticals Holdings Inc. RVPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1829831 Prabhu Narayan C/O Reviva Pharmaceuticals Holdings, Inc
19925 Stevens Creek Blvd, Suite 100
Cupertino CA 95014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2022-06-30 50,000 $1.21 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.37 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.